serum aspartate aminotransferase level and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis c
Current Language EN
English English Türkçe Türkçe Español Español Português Português Pусский Pусский Filipino Filipino Tiếng Việt Tiếng Việt हिन्दी हिन्दी العربية العربية বাংলা বাংলা Deutsch Deutsch 中文 中文

serum aspartate aminotransferase level and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis c

;Tomohiro Tanaka;George Therapondos;Nazia Selzner;Eberhard L Renner;Leslie B Lilly
indian journal of pharmacology 2013 Vol. 27 pp. 131-136
250
tanaka2013canadianserum

Abstract

BACKGROUND: Hepatitis C virus (HCV) infection remains the leading indication for liver transplantation (LT) worldwide. Recurrent hepatitis C following LT is universal, and significant fibrosis (SF, Metavir fibrosis stage ≥2) apparent on protocol biopsy typically prompts antiviral therapy.

Keywords

Gastroenterology diseases of the digestive system

Access

DOI:
10.1155/2013/904636
URL:
http://dx.doi.org/10.1155/2013/904636

Citation

ID: 217351
Ref Key: tanaka2013canadianserum
Use this key to autocite in SciMatic or Thesis Manager

References

References

No Bibliography

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
217351
Unique Identifier:
10.1155/2013/904636
Network:
Scimatic Chain (ID: 481)
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet
Gas fees required in SCI Coins
Buy SCI

Saymatik Web3.0 Wallet

Google Play
App Store